77% of clinical drugs target the same 20% of popular targets—AI could fix this
jacobkimmel · x · 2026-11-14
Cited data: 77% of clinical-stage drugs go after the most popular 20% of targets, and 31% target just the top 2%. jacobkimmel argues reversing this concentration is one of humanity's great opportunities in the coming years — implying AI-driven drug discovery can open up neglected target space.
More from AGI Musings
- Recursive self-improvement has no single starting moment — Cosmos Institute essay dissects the intelligence explosion — sebkrier · 2026-11-14
- Gemini helps WSJ reporter crack her 20-year medical mystery — vivnat · 2026-11-14
- Boomi AI chief on agentic truth: enterprises need a context layer, not just clean data — jonerp · 2026-11-14
- Revisiting 'Cybernetic Serendipity': the vocabulary of digital art's origins — Merzmensch · 2026-11-14
- 'Living in a different world': an AI researcher's dispatch from the psychosis frontier — illscience · 2026-11-14
- RT: "We don't know how to make superintelligent AIs do what we want" — trevposts · 2026-11-14